Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor β1-induced furin gene transactivation

被引:104
|
作者
Blanchette, F
Rivard, N
Rudd, P
Grondin, F
Attisano, L
Dubois, CM [1 ]
机构
[1] Univ Sherbrooke, Fac Med, Div Immunol, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Sherbrooke, Fac Med, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada
[3] Univ Toronto, Dept Anat & Cell Biol, Toronto, ON M5S 1A8, Canada
关键词
D O I
10.1074/jbc.M100093200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Furin, a predominant convertase of the cellular constitutive secretory pathway, is known to be involved in the maturation of a number of growth/differentiation factors, but the mechanisms governing its expression remain elusive. We have previously demonstrated that transforming growth factor (TGF) beta1, through the activation of Smad transducers, regulates its own converting enzyme, furin, creating a unique activation/regulation loop of potential importance in a variety of cell fate and functions. Here we studied the involvement of the p42/p44 MAPK pathway in such regulation. Using HepG2 cells transfected with fur P1 LUC (luciferase) promoter construct, we observed that forced expression of a dominant negative mutant form of the small G protein p21(ras) (RasN17) inhibited TGF beta1-induced far gene transcription, suggesting the involvement of the p42/p44 MAPK cascade. In addition, TGF beta induced sustained activation/phosphorylation of endogenous p42/p44 MAPK. Further-more, the role of MAPK cascade in far gene transcription was highlighted by the use of the MEK1/2 inhibitors, PD98059 or U0126, or co-expression of a p44 antisense construct that repressed the induction of fur promoter transactivation. Conversely, overexpression of a constitutively active form of MEK1 increased unstimulated, TGF beta1-stimulated, and Smad2-stimulated promoter P1 transactivation, and the universal Smad inhibitor, Smad7, inhibited this effect. Activation of Smad2 by MEK1 or TGF beta1 resulted in an enhanced nuclear localization of Smad2, which was inhibited upon blocking MEK1 activity. Our findings clearly show that the activation of the p42/p44 MAPK pathway is involved in far gene expression and led us to propose a co-operative model whereby TGF beta1-induced receptor activation stimulates not only a Smad pathway but also a parallel p42/p44 MAPK pathway that targets Smad2 for an increased nuclear translocation and enhanced fur gene transactivation. Such an uncovered mechanism may be a key determinant for the regulation of furin in embryogenesis and growth-related physiopathological conditions.
引用
收藏
页码:33986 / 33994
页数:9
相关论文
共 50 条
  • [21] Rac regulates collagen-induced HSP27 phosphorylation via p44/p42 MAP kinase in human platelets
    Kageyama, Yasunari
    Doi, Tomoaki
    Akamatsu, Shigeru
    Kuroyanagi, Gen
    Kondo, Akira
    Mizutani, Jun
    Otsuka, Takanobu
    Tokuda, Haruhiko
    Kozawa, Osamu
    Ogura, Shinji
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 (04) : 813 - 818
  • [22] (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: Inhibition of p44/p42 MAP kinase activation
    Tokuda, Haruhiko
    Takai, Shinji
    Hanai, Yoshiteru
    Matsushima-Nishiwaki, Rie
    Hosoi, Takayuki
    Harada, Atsushi
    Ohta, Toshiki
    Kozawa, Osamu
    FEBS LETTERS, 2007, 581 (07) : 1311 - 1316
  • [23] Involvement of protein kinase C-dependent mitogen-activated protein kinase p44/42 signaling pathway for cross-talk between estradiol and transforming growth factor-β3 in increasing basic fibroblast growth factor in folliculostellate cells
    Chaturvedi, K
    Sarkar, DK
    ENDOCRINOLOGY, 2004, 145 (02) : 706 - 715
  • [24] Possible involvement of p44/p42 MAP kinase in retinoic acid-stimulated vascular endothelial growth factor release in aortic smooth muscle cells
    Tanabe, K
    Hirade, K
    Ishisaki, A
    Shu, E
    Suga, H
    Kitajima, Y
    Katagiri, Y
    Dohi, S
    Kozawa, O
    ATHEROSCLEROSIS, 2004, 175 (02) : 245 - 251
  • [25] Selective HIF-1 Regulation under Nonhypoxic Conditions by the p42/p44 MAP Kinase Inhibitor PD184161
    Jalouli, Maroua
    Mokas, Sophie
    Turgeon, Catherine A.
    Lamalice, Laurent
    Richard, Darren E.
    MOLECULAR PHARMACOLOGY, 2017, 92 (05) : 510 - 518
  • [26] Biological cross-talk between WNK1 and the transforming growth factor β-Smad signaling pathway
    Lee, Byung-Hoon
    Chen, Wei
    Stippec, Steve
    Cobb, Melanie H.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (25) : 17985 - 17996
  • [27] Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor
    Iwasaki, H
    Eguchi, S
    Ueno, H
    Marumo, F
    Hirata, Y
    ENDOCRINOLOGY, 1999, 140 (10) : 4659 - 4668
  • [28] HSP90 inhibitors diminish PDGF-BB-induced migration of osteoblasts via suppression of p44/p42 MAP kinase
    Kawabata, Tetsu
    Tokuda, Haruhiko
    Fujita, Kazuhiko
    Matsushima-Nishiwaki, Rie
    Sakai, Go
    Tachi, Junko
    Hioki, Tomoyuki
    Kim, Woo
    Ilda, Hiroki
    Otsuka, Takanobu
    Kozawa, Osamu
    BIOMEDICAL RESEARCH-TOKYO, 2019, 40 (04): : 169 - 178
  • [29] Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate
    Schwenger, P
    Skolnik, EY
    Vilcek, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (14) : 8089 - 8094
  • [30] Fibroblast growth factor receptor-1 enhances p42/p44 MAPK signaling in pancreatic islet β-cells.
    Kilkenny, Dawn M.
    Rocheleau, Jonathan V.
    BIOPHYSICAL JOURNAL, 2007, : 434A - 434A